A multiple cancer study by Cybulski et al. [20] identified an increased risk of thyroid cancer, particularly in carriers of CHEK2 truncations (OR = 4.9) and, to a lesser extent, in carriers of p.I157T (OR = 1.9). Here, CHEK2 is linked to thyroid gland carcinoma.